Baxter International has acquired Baxa, the US-based developer of pharmacy technology, for a cash consideration of $380m.

Baxter Medical Products develops, manufactures and markets products used in the delivery of fluids and drugs to patients.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Baxter Medical Products business president Robert Davis said the transaction will allow Baxter to provide a broader range of solutions for the safe preparation and delivery of IV medications.

"We believe Baxa’s expertise in safely preparing IV and oral liquid medications, and their shared commitment toward improving patient care through innovative drug preparation and delivery technology, will benefit patients around the world," Davis added.

Baxter’s product portfolio includes ExactaMix, ExactaMed syringes, NeoThrive enteral feeding system, enteral syringes and accessories and the DoseEdge pharmacy workflow manager for managing IV and oral dose preparation activities.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now